These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 200843)

  • 1. Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo.
    Abdou NI; NaPombejara C; Sagawa A; Ragland C; Stechschulte DJ; Nilsson U; Gourley W; Watanabe I; Lindsey NJ; Allen MS
    N Engl J Med; 1977 Dec; 297(26):1413-9. PubMed ID: 200843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa: evidence for a bactericidal defect correctable by cholinergic agonist in vitro and in vivo.
    Ginder PA; Ousley M; Hinthorn D; Liu C; Abdou NI
    J Clin Immunol; 1982 Jul; 2(3):237-41. PubMed ID: 6126491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malakoplakia: evidence for an acquired disease secondary to immunosuppression.
    Biggar WD; Keating A; Bear RA
    Transplantation; 1981 Feb; 31(2):109-12. PubMed ID: 7020170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.
    Oliver JM
    Am J Pathol; 1976 Nov; 85(2):395-418. PubMed ID: 187062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytic function in malakoplakia.
    Schreiber AG; Maderazo EG
    Arch Pathol Lab Med; 1978 Oct; 102(10):534-7. PubMed ID: 361018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malakoplakia and immunosuppressive therapy. Reversal of clinical and leukocyte abnormalities after withdrawal of prednisone and azathioprine.
    Biggar WD; Crawford L; Cardella C; Bear RA; Gladman D; Reynolds WJ
    Am J Pathol; 1985 Apr; 119(1):5-11. PubMed ID: 3885752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malakoplakia at 3 sites: the bladder, urethra and kidney. Isolation and ultrastructural study of blood monocytes].
    Kantelip B; Auge MC; Boiteux JP; Chassagne M
    Ann Pathol; 1987; 7(2):143-8. PubMed ID: 3040028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate.
    Boxer LA; Watanabe AM; Rister M; Besch HR; Allen J; Baehner RL
    N Engl J Med; 1976 Nov; 295(19):1041-5. PubMed ID: 184391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malacoplakia of the bladder: efficacy of bethanechol chloride therapy.
    Zornow DH; Landes RR; Morganstern SL; Fried FA
    J Urol; 1979 Nov; 122(5):703-4. PubMed ID: 501834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticosteroid therapy on human monocyte function.
    Rinehart JJ; Sagone AL; Balcerzak SP; Ackerman GA; LoBuglio AF
    N Engl J Med; 1975 Jan; 292(5):236-41. PubMed ID: 1089191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogammaglobulinemia and malakoplakia--effect of Bethanechol.
    Soothill JF; Harvey BA; Webb M; Marshall WC; Spitz L; Pincott JR
    Birth Defects Orig Artic Ser; 1983; 19(3):329-30. PubMed ID: 6140038
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC; van den Barselaar MT; van Zwet TL; Daha MR; van Furth R
    J Clin Invest; 1979 Apr; 63(4):772-84. PubMed ID: 374424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cAMP metabolism during phagocytosis of S. aureus by human monocytes.
    Merdrignac G; Duval J; Gouranton J; Genetet B
    J Reticuloendothel Soc; 1982 Sep; 32(3):209-18. PubMed ID: 6296386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogammaglobulinaemia and malakoplakia: response to bethanechol.
    Webb M; Pincott JR; Marshall WC; Spitz L; Harvey BA; Soothill JF
    Eur J Pediatr; 1986 Sep; 145(4):297-302. PubMed ID: 2876897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colonic malacoplakia: use of bethanechol].
    Nieto-Zermeño J; Martín Del Campo-Martínez N; Sáenz-Urquidi E; Bulnes-Mendizábal D; Palet JA
    Bol Med Hosp Infant Mex; 1984 Jul; 41(7):369-73. PubMed ID: 6148091
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic and immunologic considerations in malakoplakia.
    Griggs WP; Hemstreet GP
    Urology; 1980 Dec; 16(6):638-45. PubMed ID: 6969487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malakoplakia].
    Debré B; Leleu C
    Ann Urol (Paris); 1984 Feb; 18(1):6-12. PubMed ID: 6529199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology of leukocyte abnormalities--membrane and cytoskeletal function in normal and defective cells. A review.
    Oliver JM
    Am J Pathol; 1978 Oct; 93(1):221-70. PubMed ID: 211848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfilament and microtubule function in human monocytes.
    Rinehart JJ; Boulware T
    J Lab Clin Med; 1977 Oct; 90(4):737-43. PubMed ID: 561822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.